Biomarkers of response to VEGF pathway-targeted therapy discovered for renal cell carcinoma

CHICAGO -- Angiogenesis inhibitors can be far more effective in treating metastatic clear cell renal cell cancer (RCC) - an aggressive form of the most common kind of kidney cancer that is also rich in blood supply - than traditional treatments, according to accumulating evidence. They can prolong life in about a third of patients, but researchers have not been able to identify the responding patients, prior to treatment.

Now, a research team from the University of California, San Francisco (UCSF) and the Cleveland Clinic, has found that patients whose tumors produce greater amounts of vascular endothelial growth factor (VEGF) and its receptor benefit most from these targeted treatments, because these proteins are the "targets" they are designed to go after.

"The more VEGF and VEGF receptor a patient's tumor has, the better these treatments seem to work," said the study's lead author, Erich B. Jaeger, Ph.D., a postdoctoral researcher at the UCSF Comprehensive Cancer Center. "This is very exciting because, if validated, a fairly simple test could help oncologists direct these new treatments to patients who can benefit most from them."

Results were presented at the first meeting on Molecular Diagnostics in Cancer Therapeutic Development, organized by the American Association for Cancer Research.

Clear cells RCCs often accumulate VEGF and other angiogenesis-related proteins due to mutation in the Von Hippel-Lindau (VHL) tumor suppressor gene. This gene was identified as the cause of the rare and inherited Von Hippel-Lindau disease, which is characterized by frequent development of clear cell renal tumors.

About half of non-inherited clear cell renal cell cancer is believed to result from mutations in the VHL gene, Jaeger said. The mutations prevent proper degradation of specific VHL target proteins, which leads to over-expression of VEGF and other proteins associated with angiogenesis, he said. These proteins cause the t

Contact: Warren Froelich
American Association for Cancer Research

Page: 1 2

Related biology news :

1. Biomarkers may hone anti-aging therapies
2. Biomarkers isolated from saliva successfully predict oral and breast cancer
3. MIT model could predict cells response to drugs
4. Strength of connections between brain regions may affect an adolescents response to peer influence
5. A friendly foe -- Bacteria residing in the gut boost immune response to tumors
6. Identified main genetic variants involved in response to HIV
7. Minister Lunn announces $39.6M for next phase of mountain pine beetle response
8. Columbine flowers develop long nectar spurs in response to pollinators
9. PET accurately identifies esophageal cancer patients positive responses to chemotherapy
10. Every moment counts: Predicting treatment responses earlier for brain tumor patients
11. FDG-PET imaging clearly predicts lung cancer patients response to chemotherapy

Post Your Comments:

(Date:6/4/2019)... ... June 04, 2019 , ... ... for salient features of seizure risk signals, usually based on variations of amplitude, ... remains the only acceptable diagnostic methodology due to the complexity and variability of ...
(Date:6/1/2019)... , ... May 31, 2019 , ... ... Sonsini Goodrich & Rosati recently invested in BioFactura’s $6M Series B Financing Round. ... now securing value-added institutional investors who bring significant financial and business resources to ...
(Date:5/31/2019)... ... 30, 2019 , ... Join Julie Peacock, Vice President of ... Wednesday, June 19, 2019 at 1pm EDT where she will demonstrate how role-based ... and contract research organizations (CROs) can improve collaboration, auditing, document tracking and reporting. ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... MONTREAL (PRWEB) , ... June 10, 2019 , ... ... growth of its distribution network with the appointment of Biofeedback Tech Ltd ... physiological monitoring systems are an essential part of many therapeutic treatments and clinical ...
(Date:6/11/2019)... ... June 10, 2019 , ... ... 80 of its scientific journals to DeepDyve’s rental service for peer-reviewed journals. ... expanding library of more than 20 million articles, sourced from more than 15,000 ...
(Date:6/11/2019)... , ... June 11, 2019 , ... ... Personalized Stem Cells Inc. (PSC) , has announced that their GMP facility ... Food and Drug Branch for manufacturing. This is an important milestone for ...
(Date:6/6/2019)... ... June 05, 2019 , ... WCCT Global, Inc ... device industries, announced today that they will be receiving 3 awards at the 2019 ... WCCT received 2 awards in the categories of overall Quality and Compatibility (Access to ...
Breaking Biology Technology:
Cached News: